Sharekhan

Healthcare Global Enterprises Ltd

Mon 1/12/2025,15:59:43 NSE: HCG

₹ 739.00 8.65 (1.18%)
BUY NOW Buy Healthcare Global Enterprises Ltd Stock

Open Free Demat and Trading account in 15 minutes

Home Stock Healthcare Global Enterprises Ltd

Mon 1/12/2025,16:1:0

Healthcare Global Enterprises Ltd

Mon 1/12/2025,15:59:43 | NSE : HCG

₹ 739.008.65 (1.18%)

Data is delayed. Analysis is best done in real-time! Open a FREE Sharekhan Demat A/c in 15 mins* and continue your analysis with real-time data.

Market Data

Essential tool: analyze, trade, manage, decide.

Open

₹ 724.25

Previous Close

₹ 730.35

Volume

248488

Mkt Cap ( Rs. Cr)

₹10419.91

High

₹ 745.00

Low

₹ 722.00

52 Week High

₹ 804.65

52 Week Low

₹ 456.95

Book Value Per Share

₹ 61.23

Dividend Yield

0.00

Face Value

₹ 10.00

What’s Your Call?

Collective community sentiment on Healthcare Global Enterprises Ltd

Your Vote -

Buy

66.67%

Hold

25.00%

Sell

8.33%

66.67%

12 users have voted

Market Depth

How many stocks are available to buy or sell and at what prices.

Buy Order Quantity

100%

Sell Order Quantity

0%

Bid Price

Qty

739.00

12

0.00

0

0.00

0

0.00

0

0.00

0

Bid Total

12

Bid Price

Qty

0.00

0

0.00

0

0.00

0

0.00

0

0.00

0

Bid Total

0

Option Chain

Analyzes market sentiment, predicts Healthcare Global Enterprises Ltd' movement.

NO_RECORD_FOUND

News

Media spotlight triggers stock stock attention, sentiment.

  • Healthcare Global En - Appointment Of Internal Auditor Of The Company Under Section 138 Of The Companies Act, 2013.

    1 Dec 2025, 3:14PM Appointment of Mr. Vijay S Shanbhag, the Chief Internal Auditor of the Company as the Internal Auditor under Section 138 of the Companies Act, 2013 ef

  • Healthcare Global En - Announcement under Regulation 30 (LODR)-Change in Management

    1 Dec 2025, 3:09PM Pursuant to Regulation 30 read with Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform you tha

  • Healthcare Global En - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

    22 Nov 2025, 1:59PM Further to our intimation dated November 11, 2025 regarding the virtual Investor and Analyst Meet scheduled on December 04, 2025, to share updates on

  • Healthcare Global En - Analysts/Institutional Investor Meet/Con. Call Updates

    22 Nov 2025, 1:54PM Healthcare Global Enterprises Limited has informed the Exchange about Schedule of meet

  • Healthcare Global En - Updates

    13 Nov 2025, 4:25PM This is to inform you that the Board of Directors of the Company, at its meeting held on November 12, 2025, considered and approved the Unaudited Fina

  • Healthcare Global En - Copy of Newspaper Publication

    13 Nov 2025, 12:51PM Healthcare Global Enterprises Limited has informed the Exchange about Copy of Newspaper Publication of unaudited financial results (Standalone and Con

  • Healthcare Global En - Shareholders meeting

    25 Sep 2025, 9:10PM Healthcare Global Enterprises Limited has informed the Exchange regarding Proceedings of Annual General Meeting held on September 25, 2025

  • Healthcare Global En - Shareholder Meeting / Postal Ballot-Outcome of AGM

    25 Sep 2025, 9:10PM Proceedings of 27th Annual General Meeting of the Company held on September 25, 2025.

  • Healthcare Global En - Unaudited Financial Results (Standalone And Consolidated) For Quarter And Six Months Ended September 3

    13 Nov 2025, 4:24PM This is to inform you that the Board of Directors of the Company, at its meeting November 12, 2025, considered and approved the Unaudited Financial R

  • Healthcare Global En - Investor Presentation

    12 Nov 2025, 9:30PM Healthcare Global Enterprises Limited has informed the Exchange about Investor Presentation

  • Healthcare Global En - Announcement under Regulation 30 (LODR)-Investor Presentation

    12 Nov 2025, 9:29PM Investor Presentation on unaudited financial results (Standalone and Consolidated) of the Company for the quarter and half year ended September 30, 20

  • Healthcare Global En - Press Release

    12 Nov 2025, 9:25PM Healthcare Global Enterprises Limited has informed the Exchange regarding a press release dated November 12, 2025 with respect to Q2 & H1FY26 Financia

  • Healthcare Global En - Announcement under Regulation 30 (LODR)-Press Release / Media Release

    12 Nov 2025, 9:25PM Press release dated November 12, 2025, with respect unaudited financial results (Standalone and Consolidated) of the Company for the quarter and half

  • Healthcare Global En - General Updates

    12 Nov 2025, 7:42PM Healthcare Global Enterprises Limited has informed the Exchange about investment in three (03) Wholly Owned Subsidiaries by the Company.

  • Healthcare Global En - Announcement under Regulation 30 (LODR)-Acquisition

    12 Nov 2025, 7:41PM Investments in three (03) wholly owned subsidiaries of the Company.

  • Healthcare Global En Q2 net profit down 32.75% at Rs 10.78 cr

    12 Nov 2025, 7:15PM The company reported standalone net profit of Rs 10.78 crore for the quarter ended September 30, 2025 as compared to Rs 16.03 crore in the same period

  • Healthcare Global En - Issuance Of Guarantee In The Form Of A Standby Letter Of Credit (SBLC) To Secure Credit Facilities Pro

    12 Nov 2025, 7:03PM Issuance of guarantee in the form of Standby Letter of Credit (SBLC) to secure credit facilities proposed to be availed by Cancer Care Kenya Limited,

  • Healthcare Global En - Giving guarantees/indemnity/ becoming a surety for third party

    12 Nov 2025, 7:00PM Healthcare Global Enterprises Limited has informed the Exchange about issuance of guarantee in the form of a Standby Letter of Credit (SBLC) to secure

  • Healthcare Global En - General Updates

    12 Nov 2025, 6:57PM Healthcare Global Enterprises Limited has informed the Exchange about acquisition of up to 10% equity stake in Cancer Care Kenya Limited, step-down su

  • Healthcare Global En - Announcement under Regulation 30 (LODR)-Acquisition

    12 Nov 2025, 6:49PM Acquisition of up to 10% equity stake in Cancer Care Kenya Limited, step-down subsidiary of the Company in Kenya.

  • Healthcare Global En - Change in Management

    12 Nov 2025, 6:34PM Healthcare Global Enterprises Limited has informed the Exchange about Appointment of Mr. Manu Sharma Das as the Chief Marketing Officer of the Company

  • Healthcare Global En - Announcement under Regulation 30 (LODR)-Change in Management

    12 Nov 2025, 6:30PM Appointment of Mr. Manu Shankar Das as Chief Marketing Officer of the Company (Senior Management Personnel) who shall join on or before December 20, 2

  • Healthcare Global En - Outcome of Board Meeting

    12 Nov 2025, 6:08PM Healthcare Global Enterprises Limited has submitted to the Exchange, the financial results for the quarter and six months ended September 30, 2025.

  • Healthcare Global En - Unaudited Financial Results Of The Company (Standalone And Consolidated), For The Quarter And Six Mont

    12 Nov 2025, 6:03PM Approval of unaudited financial results of the Company (Standalone and Consolidated), for the quarter and six months ended September 30, 2025.

  • Healthcare Global En - Outcome of Board Meeting

    12 Nov 2025, 5:55PM Healthcare Global Enterprises Limited has informed the Exchange regarding Outcome of the Board meeting held on November 12, 2025.

  • Healthcare Global En - Board Meeting Outcome for Approval Of Unaudited Financial Results Of The Company (Standalone And Conso

    12 Nov 2025, 5:54PM Approval of unaudited Financial Results of the Company (Standalone and Consolidated), for the quarter and six months ended September 30, 2025.

  • Healthcare Global En - Analysts/Institutional Investor Meet/Con. Call Updates

    11 Nov 2025, 1:11PM Healthcare Global Enterprises Limited has informed the Exchange about Schedule of meet

  • Healthcare Global En - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

    11 Nov 2025, 1:08PM Investor and Analyst Meet has been scheduled on Thursday, December 4, 2025, at 4:00 p.m. onwards, wherein the Management will share updates on the Com

  • Healthcare Global En - Board Meeting Intimation for Intimation Of The Meeting Of The Board Of Directors Of Healthcare Global

    5 Nov 2025, 3:52PM Healthcare Global Enterprises Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/11/2025 ,inter alia, to

  • Healthcare Global En - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

    17 Oct 2025, 3:46PM Certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended September 30, 2025.

  • Healthcare Global En - Certificate under SEBI (Depositories and Participants) Regulations, 2018

    17 Oct 2025, 3:46PM Healthcare Global Enterprises Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018 for the

  • Healthcare Global En has submitted to BSE the Shareholding Pattern for the Period Ended September 30, 2025

    16 Oct 2025, 7:20PM As of September 2025, 63.78% is owned by Promoters and 36.22% by Public. <p align=justify> Among Promoters holding, Indian Promoters holds 9.94% and F

  • Healthcare Global En - Trading Window

    26 Sep 2025, 6:31PM Healthcare Global Enterprises Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading)

  • Healthcare Global En - Shareholder Meeting / Postal Ballot-Scrutinizer's Report

    26 Sep 2025, 6:06PM We are enclosing herewith the Consolidated Scrutinizers' Report dated September 26, 2025 and Voting Results in accrodance with Regulation 44 (3) of

  • Healthcare Global En - Shareholders meeting

    26 Sep 2025, 6:04PM Healthcare Global Enterprises Limited has submitted the Exchange a copy Srutinizers report of Annual General Meeting held on September 25, 2025. Furt

  • Healthcare Global En - Shareholder Meeting / Postal Ballot-Scrutinizer's Report

    26 Sep 2025, 6:06PM We are enclosing herewith the Consolidated Scrutinizers' Report dated September 26, 2025 and Voting Results in accrodance with Regulation 44 (3) of

  • Healthcare Global En - Shareholder Meeting / Postal Ballot-Scrutinizer's Report

    26 Sep 2025, 6:06PM We are enclosing herewith the Consolidated Scrutinizers' Report dated September 26, 2025 and Voting Results in accrodance with Regulation 44 (3) of

  • Healthcare Global En - ESOP/ESOS/ESPS

    12 Sep 2025, 8:34PM Healthcare Global Enterprises Limited has informed the Exchange regarding Allotment of 1584730 Equity Shares.

  • Healthcare Global En - Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS

    12 Sep 2025, 8:31PM Approval for issuance and allotment of 15,84,730 equity shares of the Company of INR 10 each, upon exercise of Employee Stock Options in accordance wi

  • Healthcare Global En - Appointment

    12 Sep 2025, 8:20PM Healthcare Global Enterprises Limited has informed the Exchange regarding Appointment of Mr Gopi Lama as Head of Domestic Sales of the company w.e.f.

  • Healthcare Global En - Announcement under Regulation 30 (LODR)-Change in Management

    12 Sep 2025, 8:14PM Appointment of Mr Gopi Lama as the Head of Domestic Sales (Senior Management Personnel) of the Company with effect from September 15, 2025.

  • Healthcare Global En - Reg. 34 (1) Annual Report.

    3 Sep 2025, 8:57PM Notice of 27th Annual General Meeting and Integrated Annual Report of the Company for FY 2024-25.

  • Healthcare Global En - Shareholders meeting

    3 Sep 2025, 8:46PM Healthcare Global Enterprises Limited has informed the Exchange regarding Notice of Annual General Meeting to be held on September 25, 2025

  • Healthcare Global En - Notice Of 27Th Annual General Meeting And Integrated Annual Report Of The Company For FY 2024-25.

    3 Sep 2025, 8:45PM Notice of 27th Annual General Meeting and Integrated Annual Report of the Company for FY 2024-25.

  • Healthcare Global En - Business Responsibility and Sustainability Reporting (BRSR)

    3 Sep 2025, 11:45AM Business Responsibility and Sustainability Reporting (BRSR) of the Company for the year ended March 31, 2025.

  • Healthcare Global En - Cessation

    2 Sep 2025, 10:58PM Healthcare Global Enterprises Limited has informed the Exchange regarding resignation of Ms. Ruby Ritilia as Chief Financial Officer of the company w

  • Healthcare Global En - Announcement under Regulation 30 (LODR)-Resignation of Chief Financial Officer (CFO)

    2 Sep 2025, 10:58PM Resignation of Ms. Ruby Ritolia, Chief Financial Officer (\CFO\) of the Company effective from September 02, 2025.

  • Healthcare Global En - Copy of Newspaper Publication

    2 Sep 2025, 1:24PM Healthcare Global Enterprises Limited has informed the Exchange about Copy of Newspaper Publication

  • Healthcare Global Enterprises

    11 Sep 2025 , 1:20PM Healthcare Global Enterprises : Aceso Company, part of the CVC Network, has sold nearly a 6% stake in the company via a block deal on the NSE, raising Rs.552 crore at an average price of Rs. 695 per share. Of the 79 lakh shares sold, Nippon India Mutual Fund bought 44 lakh shares worth Rs. 306 crore, increasing its stake by 3.2% on top of the 2.5% it already held as of June 2025. Other buyers included Plutus Wealth Management (Rs. 50 crore), Axis Mutual Fund (Rs. 66 crore), and Morgan Stanley Asia Singapore (₹61 crore). Motilal Oswal AMC also picked up three lakh shares worth Rs. 21 crore.

  • Healthcare Global Enterprises

    24 Feb 2025 , 9:03AM American private-equity giant KKR & Co will acquire up to a 54 per cent stake in hospital chain Healthcare Global Enterprises (HCG) from CVC Asia V for $400 million (approximately Rs 3,465 crore). KKR will purchase shares of HCG at Rs 445 apiece (11% discount to CMP) and make an open offer to the company’s shareholders to buy an additional 26 per cent. Negative

  • Healthcare Global to acquire majority stake in Vizag Hospital

    28 Jun 2024 , 1:54PM The company shall acquire a further 34% stake at Rs. 155 crore

  • Healthcare Global Enterprises

    27 Sep 2023 , 10:01AM According to media reports, Private equity firm CVC Capital Partners is considering selling a 60.4% stake in Indian cancer hospital chain HealthCare Global Enterprises. The stake is worth about $345 million (currently value at Rs2885crore). CVC may seek a premium of 20% for the shares or go as high as 50% depending on market conditions.

  • Healthcare Global Enterprises

    7 Jul 2023 , 11:22AM The Company entered into a Share Purchase Agreement with Dr Ajay Mehta, Dr Suchitra Mehta and shareholders of NCHRI, for the acquisition of entire equity share capital in Nagpur Cancer Hospital & Research Institute Pvt. Ltd (NCHRI). The completion of the acquisition is subject to the receipt of requisite approvals by NCHRI and other conditions. HCG currently holds 76% stake in the 115 beds Hospital. Post the acquisition it will be 100% subsidiary of the company. The cost of acquisition of entire shares (100%) in NCHRI would be INR 14.1 Crores, and the consideration payable to Dr.Ajay Mehta for the transfer of his partnership interest in HCG NCHRI LLP would be INR 17.6 Crores (which includes deferred consideration of INR 4.2 Crores). The turnover of NCHRL in FY2023 stood at ~Rs8crore with EBIDTA of Rs7.6crore.

  • Viewpoint: Healthcare Global Enterprises

    23 Mar 2023 , 2:06PM Viewpoint: Healthcare Global Enterprises – Improved growth visibility with favourable risk-reward

  • View Point: Healthcare Global Enterprises

    13 Dec 2022 , 11:09AM View Point: Healthcare Global Enterprises - Drivers in place to achieve consistent growth

  • Healthcare global enterprises

    2 Dec 2022 , 10:35AM Care rating has revised upwards the rating for the company to Care A+; Outlook – stable from Care A; outlook – stable. The revision in the rating assigned to the bank facilities of the company factors in the strong recovery in admissions and procedures performing translating into sustained improvement in its revenues and profitability – Positive read thru; preferred stock in the Hospital space.

  • Healthcare Global Enterprises

    20 Sep 2022 , 11:31AM BACC Health Care Private Limited (“Milann”), Wholly Owned Subsidiary of Healthcare Global Enterprises (HCG), is in discussions with Neonatal Care & Research Institute Private Limited (“Ovum”) with respect to a proposal for entering into a business combination arrangement, whereby HCG, post the completion of the Transaction, may hold a majority of the shareholding in the resultant entity. Ovum Hospitals, run by the Neonatal Care & Research Institute (NCRI), is an organization formed by a group of doctors with national and international experience in the field of pediatrics and gynaecology. It has around five centres in an around the city of Bangaluru.

  • Viewpoint: Healthcare Global

    27 Jun 2022 , 10:33AM Viewpoint: Healthcare Global - Bed capacity expansion and improved profitability to drive growth ahead

  • Healthcare Global Enterprises

    24 Jun 2022 , 10:34AM Healthcare Global Enterprises: The company Acquires radiant hospitals in Odisha, like to acquire majority stake in Cancer hospital in Nagpur

  • Healthcare Global Enterprises

    24 Jun 2022 , 9:42AM The company Acquires radiant hospitals in Odisha, like to acquire majority stake in Cancer hospital in Nagpur and setting 25 bed capacity in Bangalore and expanding Ahmedabad hospital bed capacity (10-11% addition in the bed capacity 1720 over the next two years).

  • HCG acquires majority stake in Suchirayu HealthCare Solutions

    22 Nov 2021 , 10:02AM Acquisition of majority stake in Suchirayu Health care Solutions, Hubli, Karnataka.

  • Viewpoint: Healthcare Global - Q2FY22

    15 Nov 2021 , 2:13PM Viewpoint: Healthcare Global - Q2FY22 consolidated results review

  • HCG Q2FY022 consolidated

    12 Nov 2021 , 10:32AM Healthcare Global Enterprises: (HCG) Q2FY022 consolidated – strong operating performance

  • Healthcare Global Enterprises

    13 Oct 2021 , 9:56AM Healthcare Global Enterprises: Operations return to regular level post second wave; revenue stream at all time high

  • Healthcare Global Enterprises

    29 Sep 2021 , 12:16PM ICRA has upgraded long term – term loan/cash credit /overdraft to A+ (stable) from A- and on short term – non-fund based to A1 from A2+ - Positive read through for Healthcare Global Enterprises

  • Viewpoint: Healthcare Global Enterprises

    17 Sep 2021 , 9:58AM Viewpoint: Healthcare Global Enterprises - Unique business model to drive healthy cash flows

  • Healthcare Global Enterprises

    16 Sep 2021 , 10:50AM Rating agency care has upgraded rating of long term bank facilities of Rs489.2crore to Single A and Outlook stable – Positive read through for the stock.

  • HealthCare Global acquires oncology hospital labs from Strand Lifesciences

    6 Sep 2021 , 2:35PM HCG acquires oncology labs and divests stake in Strand Lifesciences to Reliance

  • Healthcare Global Enterprises

    6 Sep 2021 , 10:23AM The company acquires oncology labs & clinical trial business strand Lifesciences and simultaneously divested 38.5% stake in Strand to Reliance Industries HCG focusing on oncology, acquired oncology hospital labs and clinical trials business from Strand Lifesciences and simultaneous divestment of its ~38.5% stake (on paid-up capital basis and 34.5% on fully diluted basis) in Strand to Reliance Industries. HCG received consideration of ~INR 157cr for sale of its ownership in Strand and acquired labs and clinical research business through a Business Transfer Agreement (BTA) from Strand for a consideration of ~INR 81cr with a set-off of ~INR 7cr towards receivables. The transactions resulted in net cash inflow of ~INR 83cr for HCG in addition to the take-over of the labs and clinical research business. Strand will no longer continue to be an associate company of HCG post completion of this transaction

  • Healthcare Global board approves preferential allotment

    23 Nov 2017 , 11:17AM Healthcare Global announces that it will issue 11.66 lakh shares at Rs300 each on a preferential basis to Indgrowth Capital Fund 1

  • Healthcare Global to set up 12 hospitals in 18 months

    23 Aug 2017 , 9:18AM Healthcare Global Enterprises (HCG) plans to set up a dozen new hospitals over the next 18 months - positive read through for the stock.
Load More
Show Less

Key fundamentals

Evaluate the intrinsic value of Healthcare Global Enterprises Ltd stock 

Name March-25 March-24 March-23 March-22 March-21
Assets 1842.61 1584.073 1266.619 1205.14 1137.922
Liabilities 1842.61 1584.073 1266.619 1205.14 1137.922
Equity 139.416 139.29 139.116 139.012 125.359
Gross Profit 215.316 196.251 180.262 149 75.632
Net Profit 3.527 33.959 40.191 38.253 -191.547
Cash From Operating Activities 145.951 194.709 130.396 124.395 70.887
NPM(%) 0.27 3.08 3.99 4.48 -31.34
Revenue 1280.489 1099.29 1005.573 851.961 611.028
Expenses 1065.173 903.039 825.311 702.961 535.396
ROE(%) 0.4 3.93 4.65 4.43 -22.18

Shareholding Pattern

Corporate Action

XD-Date Dividend-Amount Dividend-% Dividend Yield(%GE) Price on that day

Peers

Other companies within the same industry or sector that are comparable to Healthcare Global Enterprises Ltd

Company Price Price (% change) pe(x) EV/EBITDA(x) ROE(%) ROCE(%)
Albert David Ltd 784.10 -1.11 0.00 420.73 301.39 0.64
Lotus Eye Hospital and Institute Ltd 105.11 -0.51 328.47 1533.10 3.55 0.00
Vaishali Pharma Ltd 8.77 -0.23 0.00 9617.67 3.13 0.00
Astec Lifesciences Ltd 819.70 -2.17 0.00 1445.75 -604.77 0.00

Company Info

The Company was originally incorporated as Curie Centre of Oncology Private Limited on March 12, 1998 at Bengaluru, Karnataka, India as a private limited company under the Companies Act, 1956. The name of the Company was subsequently changed to HealthCare Global Enterprises Private Limited and a fresh certificate of incorporation consequent upon change of name was issued by the RoC on November 14, 2005. the Company was converted into a public limited company pursuant to a special resolution passed by the Shareholders at the EGM held on May 20, 2006 and the name of the Company was changed to HealthCare Global Enterprises Limited. A fresh certificate of incorporation consequent upon conversion to a public limited company was issued by the RoC on July 5, 2006. Major events and milestones of the Company : 2005 -Entered into the clinical laboratory business through acquisition of Triesta Sciences Inc. and Triesta Sciences (India) Private Limited 2006 -India Development Fund made its first investment of 500 million in the Company -BMORCL became the Subsidiary 2007 -HCG Medi-Surge became the Subsidiary -Evolvence made its first investment of 225 million in the Company 2008 -NTICPL made its first investment of 400 million in the Company 2009 -Amalgamation of Triesta Sciences (India) Private Limited and Triesta Sciences Inc. with the Company 2010 -IL&FS Trust Company Limited a/c MPEF, through its scheme India Build Out Fund I and MAT made its first investment of 312 million in the Company 2011 -Amalgamation of BMORCL with the Company -PIOF became a Shareholder by purchasing shares from NTICPL 2013 -V-Sciences made its first investment of `600 million in the Company -Entered into the fertility business through acquisition of 50.10% stake in BACC Healthcare 2014 -Demerger of multispecialty division from HCG Medi-Surge and vesting of the same with the Company 2015 -HCG Regency became the Subsidiary -Amalgamation of HCG Vijay with the Company -HCG was recognised by the Department of Scientific and Industrial Research, Ministry of Science and Technology, Government of India in 2015 for its in-house research and development activities at HCG Towers, Bengaluru. -At Frost and Sullivan 7th Annual Indian Healthcare Excellence Awards in 2015, Milann was recognised as the `Emerging IVF Service Provider Company of the Year'. 2016 -Company has entered into a Joint Venture Agreement on November 22, 2016, with HCG Regency Oncology Healthcare Pvt. Ltd -All India Critical Care Hospital Ranking Survey - 2016 -HCG Launches Advanced Comprehensive Cancer Centre in Baroda -Launch of HCG Vizag -HCG inaugurates TomoTherapy at its Centre of Excellence -HCG - The Specialist in Cancer Care has been presented with the prestigious title of the `Best Medical Tourism Centre of Gujarat' during the Tourism Awards 2017 event. 2017 -HCG The Specialist in Cancer Care has been presented with the prestigious title of the `Best Medical Tourism Centre of Gujarat' during the Tourism Awards 2017 event. 2018 -Healthcare Global Enterprises Limited has approved the Scheme of Amalgamation of DKR with BACC on January 29, 2018 (?the Scheme?). BACC is a subsidiary of the Company, and DKR is a wholly owned subsidiary of BACC. -HCG Hospitals, Bhavnagar was recognised as the `Best Multispeciality Hospital' in Bhavnagar by Saurashtra Samachar in 2018. -HCG Cancer Centre, Ahmedabad was awarded as the `Best Cancer Hospital' by DivyaBhaskar in 2018. 2019 -Milann has been honoured with The National Icon Award 2018-19 for being `India's Most Trusted IVF Centre'. 2020 -During the 6th India Health and Wealth Awards in 2020, HealthCare Global Enterprises Ltd was recognised for its efficient COVID management initiatives. -During the 6th India Health and Wealth Awards in 2020, HCG Hospitals, Ahmedabad was honoured with the `Silver Award' under the COVID Care Brand category. -During the 6th India Health and Wealth Awards in 2020, HCG Hospitals, Ahmedabad was honoured with the `Silver Award' under the COVID Care Brand category. 2021 -Three centres from the HCG network, namely Bangalore, Mumbai and Vadodara bagged 1st, 3rd and 6th positions under the National Single Speciality - Oncology category in the Times Health's All India Critical Care Hospital Ranking Survey 2021. -Milann has been recognised as `The Best Fertility and IVF Chain in India' by ET Healthcare Brands. -HCG Cancer Centre, Ahmedabad, has been honoured with the Times Healthcare Leaders Ahmedabad 2021 Awards for `Excellence in Oncology' and `Excellence in Innovative Technology'. -HCG Cancer Centre, Ahmedabad, was ranked amongst the World's Best Hospitals 2021 by Newsweek Magazine. 2023 -HCG Cancer Hospital collaborates with Intuitive to deepen accessibility of Robotic-Assisted Surgery across India -HealthCare Global Enterprises Limited becomes India's first mercury-free cancer care chain of hospitals. 2024 -The Company completed of acquisition of shares of Vizag Hospital and Cancer Research Centre Private Limited. -Healthcare Global Enterprises Ltd (HCG) partners with Trucan Diagnostics to Pioneer New Diagnostic Tests for Treatment Response Prediction and Monitoring in Cancer Patients. -HCG expands with two new state-of-the-art cancer care centres in Bengaluru. -HCG recognized as the Champion of India 2024 at the prestigious Dun & Bradstreet 'ESG Leadership Summit 2024'

The Company was originally incorporated as Curie Centre of Oncology Private Limited on March 12, 1998 at Bengaluru, Karnataka, India as a private limited company under the Companies Act, 1956. The name of the Company was subsequently changed to HealthCare Global Enterprises Private Limited and a fresh certificate of incorporation consequent upon change of name was issued by the RoC on November 14, 2005. the Company was converted into a public limited company pursuant to a special resolution passed by the Shareholders at the EGM held on May 20, 2006 and the name of the Company was changed to HealthCare Global Enterprises Limited. A fresh certificate of incorporation consequent upon conversion to a public limited company was issued by the RoC on July 5, 2006. Major events and milestones of the Company : 2005 -Entered into the clinical laboratory business through acquisition of Triesta Sciences Inc. and Triesta Sciences (India) Private Limited 2006 -India Development Fund made its first investment of 500 million in the Company -BMORCL became the Subsidiary 2007 -HCG Medi-Surge became the Subsidiary -Evolvence made its first investment of 225 million in the Company 2008 -NTICPL made its first investment of 400 million in the Company 2009 -Amalgamation of Triesta Sciences (India) Private Limited and Triesta Sciences Inc. with the Company 2010 -IL&FS Trust Company Limited a/c MPEF, through its scheme India Build Out Fund I and MAT made its first investment of 312 million in the Company 2011 -Amalgamation of BMORCL with the Company -PIOF became a Shareholder by purchasing shares from NTICPL 2013 -V-Sciences made its first investment of `600 million in the Company -Entered into the fertility business through acquisition of 50.10% stake in BACC Healthcare 2014 -Demerger of multispecialty division from HCG Medi-Surge and vesting of the same with the Company 2015 -HCG Regency became the Subsidiary -Amalgamation of HCG Vijay with the Company -HCG was recognised by the Department of Scientific and Industrial Research, Ministry of Science and Technology, Government of India in 2015 for its in-house research and development activities at HCG Towers, Bengaluru. -At Frost and Sullivan 7th Annual Indian Healthcare Excellence Awards in 2015, Milann was recognised as the `Emerging IVF Service Provider Company of the Year'. 2016 -Company has entered into a Joint Venture Agreement on November 22, 2016, with HCG Regency Oncology Healthcare Pvt. Ltd -All India Critical Care Hospital Ranking Survey - 2016 -HCG Launches Advanced Comprehensive Cancer Centre in Baroda -Launch of HCG Vizag -HCG inaugurates TomoTherapy at its Centre of Excellence -HCG - The Specialist in Cancer Care has been presented with the prestigious title of the `Best Medical Tourism Centre of Gujarat' during the Tourism Awards 2017 event. 2017 -HCG The Specialist in Cancer Care has been presented with the prestigious title of the `Best Medical Tourism Centre of Gujarat' during the Tourism Awards 2017 event. 2018 -Healthcare Global Enterprises Limited has approved the Scheme of Amalgamation of DKR with BACC on January 29, 2018 (?the Scheme?). BACC is a subsidiary of the Company, and DKR is a wholly owned subsidiary of BACC. -HCG Hospitals, Bhavnagar was recognised as the `Best Multispeciality Hospital' in Bhavnagar by Saurashtra Samachar in 2018. -HCG Cancer Centre, Ahmedabad was awarded as the `Best Cancer Hospital' by DivyaBhaskar in 2018. 2019 -Milann has been honoured with The National Icon Award 2018-19 for being `India's Most Trusted IVF Centre'. 2020 -During the 6th India Health and Wealth Awards in 2020, HealthCare Global Enterprises Ltd was recognised for its efficient COVID management initiatives. -During the 6th India Health and Wealth Awards in 2020, HCG Hospitals, Ahmedabad was honoured with the `Silver Award' under the COVID Care Brand category. -During the 6th India Health and Wealth Awards in 2020, HCG Hospitals, Ahmedabad was honoured with the `Silver Award' under the COVID Care Brand category. 2021 -Three centres from the HCG network, namely Bangalore, Mumbai and Vadodara bagged 1st, 3rd and 6th positions under the National Single Speciality - Oncology category in the Times Health's All India Critical Care Hospital Ranking Survey 2021. -Milann has been recognised as `The Best Fertility and IVF Chain in India' by ET Healthcare Brands. -HCG Cancer Centre, Ahmedabad, has been honoured with the Times Healthcare Leaders Ahmedabad 2021 Awards for `Excellence in Oncology' and `Excellence in Innovative Technology'. -HCG Cancer Centre, Ahmedabad, was ranked amongst the World's Best Hospitals 2021 by Newsweek Magazine. 2023 -HCG Cancer Hospital collaborates with Intuitive to deepen accessibility of Robotic-Assisted Surgery across India -HealthCare Global Enterprises Limited becomes India's first mercury-free cancer care chain of hospitals. 2024 -The Company completed of acquisition of shares of Vizag Hospital and Cancer Research Centre Private Limited. -Healthcare Global Enterprises Ltd (HCG) partners with Trucan Diagnostics to Pioneer New Diagnostic Tests for Treatment Response Prediction and Monitoring in Cancer Patients. -HCG expands with two new state-of-the-art cancer care centres in Bengaluru. -HCG recognized as the Champion of India 2024 at the prestigious Dun & Bradstreet 'ESG Leadership Summit 2024'

Read More

Parent Organisation

Healthcare Global Enterprises Ltd.

Founded

12/03/1998

Managing Director

Dr.Manish Mattoo

NSE Symbol

HCGEQ

FAQ

The current price of Healthcare Global Enterprises Ltd is ₹ 739.00.

The 52-week high for Healthcare Global Enterprises Ltd is ₹ 745.00 and the 52-week low is ₹ 722.00.

The market capitalization of Healthcare Global Enterprises Ltd is currently ₹ 10419.91. This value can fluctuate based on stock price movements and changes in the number of shares outstanding.

To buy Healthcare Global Enterprises Ltd shares, you need to have a brokerage account. First, choose a reputable brokerage firm, open an account, and complete the necessary KYC procedures.

To invest in Healthcare Global Enterprises Ltd, you need a brokerage account. After opening an account and completing the KYC process, you can fund your account and use the trading platform to purchase Healthcare Global Enterprises Ltd shares.

The CEO of Healthcare Global Enterprises Ltd is Dr.Manish Mattoo, who has been leading the company with a vision to expand its renewable energy portfolio and drive sustainable growth.

OPEN FREE* DEMAT ACCOUNT